Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.

Abstract

Therapies that target signalling molecules that are mutated in cancers can often have substantial short-term effects, but the emergence of resistant cancer cells is a major barrier to full cures. Resistance can result from secondary mutations, but in other cases there is no clear genetic cause, raising the possibility of non-genetic rare cell variability. Here we show that human melanoma cells can display profound transcriptional variability at the single-cell level that predicts which cells will ultimately resist drug treatment. This variability involves infrequent, semi-coordinated transcription of a number of resistance markers at high levels in a very small percentage of cells. The addition of drug then induces epigenetic reprogramming in these cells, converting the transient transcriptional state to a stably resistant state. This reprogramming begins with a loss of SOX10-mediated differentiation followed by activation of new signalling pathways, partially mediated by the activity of the transcription factors JUN and/or AP-1 and TEAD. Our work reveals the multistage nature of the acquisition of drug resistance and provides a framework for understanding resistance dynamics in single cells. We find that other cell types also exhibit sporadic expression of many of these same marker genes, suggesting the existence of a general program in which expression is displayed in rare subpopulations of cells.

DOI: 10.1038/nature22794

Statistics

02004002017
Citations per Year

144 Citations

Semantic Scholar estimates that this publication has 144 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Shaffer2017RareCV, title={Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.}, author={Sydney M. Shaffer and Margaret C. Dunagin and Stefan R Torborg and Eduardo A. Torre and Benjamin Emert and Clemens Krepler and Marilda Beqiri and Katrin Sproesser and Patricia A. Brafford and Min Xiao and Elliott R Eggan and Ioannis N Anastopoulos and Cesar Augusto Vargas-Garcia and Abhyudai Singh and Katherine L Nathanson and Meenhard Herlyn and Arjun Raj}, journal={Nature}, year={2017}, volume={546 7658}, pages={431-435} }